Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease.
Byrne BJ, Parenti G, Schoser B, van der Ploeg AT, Do H, Fox B, Goldman M, Johnson FK, Kang J, Mehta N, Mondick J, Sheikh MO, Sitaraman Das S, Tuske S, Brudvig J, Weimer JM, Mozaffar T.
Byrne BJ, et al. Among authors: mehta n.
Front Neurol. 2025 Jan 3;15:1540452. doi: 10.3389/fneur.2024.1540452. eCollection 2024.
Front Neurol. 2025.
PMID: 39830206
Free PMC article.